ACADIA Pharmaceuticals, Inc. (NASDAQ:ACAD)

CAPS Rating: 3 out of 5

The Company is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders.

Recs

0
Player Avatar EmpireBldr99 (78.95) Submitted: 6/15/2007 11:23:30 AM : Outperform Start Price: $15.26 ACAD Score: -81.96

Pure spec

Featured Broker Partners


Advertisement